China Resources Medical Holdings Company Limited (1PH) — Cash Flow Reinvestment Rate
China Resources Medical Holdings Company Limited (1PH) has a Cash Flow Reinvestment Rate of 0.57x as of June 2023, reinvesting €155.33 Million (capex €96.85 Million plus investments €58.49 Million) from operating cash flow of €270.22 Million. Explore 1PH capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
China Resources Medical Holdings Company Limited Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for China Resources Medical Holdings Company Limited across 9 annual periods. Also explore China Resources Medical Holdings Company asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for China Resources Medical Holdings Company Limited (2016–2024)
Year-by-year capital reinvestment analysis for China Resources Medical Holdings Company Limited. For live market cap and broader valuation context, see how much is China Resources Medical Holdings Company worth.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.44x | €564.75 Million | €1.27 Billion | €563.69 Million | ▼ -61.2% |
| 2023 | 1.15x | €1.37 Billion | €1.20 Billion | €486.68 Million | ▲ +131.4% |
| 2022 | 0.50x | €310.21 Million | €626.58 Million | €252.87 Million | ▼ -72.8% |
| 2021 | 1.82x | €1.29 Billion | €710.43 Million | €198.43 Million | ▲ +216.8% |
| 2020 | 0.58x | €370.34 Million | €643.69 Million | €209.55 Million | ▲ +21.9% |
| 2019 | 0.47x | €172.73 Million | €366.05 Million | €36.37 Million | ▼ -61.1% |
| 2018 | 1.21x | €405.67 Million | €334.15 Million | €57.61 Million | ▼ -6.6% |
| 2017 | 1.30x | €597.53 Million | €459.54 Million | €34.50 Million | ▲ +78.7% |
| 2016 | 0.73x | €162.86 Million | €223.79 Million | €42.45 Million | — |